Cargando…
Making prevention pay
Funding for biodefense is spurring new vaccine and anti-infective programs at several biotech companies.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097210/ https://www.ncbi.nlm.nih.gov/pubmed/15060549 http://dx.doi.org/10.1038/nbt0404-387 |